ID   KC1D_HUMAN              Reviewed;         415 AA.
AC   P48730; A2I2P2; Q96KZ6; Q9BTN5;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   27-JAN-2003, sequence version 2.
DT   02-NOV-2010, entry version 107.
DE   RecName: Full=Casein kinase I isoform delta;
DE            Short=CKI-delta;
DE            Short=CKId;
DE            EC=2.7.11.1;
GN   Name=CSNK1D;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   MEDLINE=96230338; PubMed=8786104; DOI=10.1006/geno.1996.0091;
RA   Kusuda J., Hidari N., Hidari M., Hashimoto K.;
RT   "Sequence analysis of the cDNA for the human casein kinase I delta
RT   (CSNK1D) gene and its chromosomal localization.";
RL   Genomics 32:140-143(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Hematopoietic stem cell;
RX   PubMed=15070676; DOI=10.1182/blood-2003-08-2768;
RA   Okamura A., Iwata N., Nagata A., Tamekane A., Shimoyama M., Gomyo H.,
RA   Yakushijin K., Urahama N., Hamaguchi M., Fukui C., Chihara K., Ito M.,
RA   Matsui T.;
RT   "Involvement of casein kinase Iepsilon in cytokine-induced
RT   granulocytic differentiation.";
RL   Blood 103:2997-3004(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NHLBI resequencing and genotyping service (RS&G);
RL   Submitted (SEP-2006) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Placenta, and Spleen;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INTERACTION WITH PER1 AND PER2.
RX   PubMed=11165242; DOI=10.1016/S0014-5793(00)02434-0;
RA   Camacho F., Cilio M., Guo Y., Virshup D.M., Patel K., Khorkova O.,
RA   Styren S., Morse B., Yao Z., Keesler G.A.;
RT   "Human casein kinase Idelta phosphorylation of human circadian clock
RT   proteins period 1 and 2.";
RL   FEBS Lett. 489:159-165(2001).
RN   [7]
RP   CATALYTIC ACTIVITY, AND INTERACTION WITH DBNDD2.
RX   PubMed=16618118; DOI=10.1021/bi052354e;
RA   Yin H., Laguna K.A., Li G., Kuret J.;
RT   "Dysbindin structural homologue CK1BP is an isoform-selective binding
RT   partner of human casein kinase-1.";
RL   Biochemistry 45:5297-5308(2006).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-350, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-331 AND SER-382, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=17192257; DOI=10.1074/mcp.T600062-MCP200;
RA   Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,
RA   Keri G., Wehland J., Daub H.;
RT   "Proteomics analysis of protein kinases by target class-selective
RT   prefractionation and tandem mass spectrometry.";
RL   Mol. Cell. Proteomics 6:537-547(2007).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-383, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-328; SER-331; THR-347;
RP   SER-382; SER-383; SER-384; THR-387; SER-396; THR-397; SER-398; SER-406
RP   AND SER-407, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-401
RP   (ISOFORM 2), AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-331; THR-347; THR-349;
RP   SER-382 AND SER-384, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-382, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-328; THR-329; SER-331;
RP   THR-337; THR-344; THR-347; THR-349; SER-350; THR-352; THR-355;
RP   SER-356; SER-361; SER-382; SER-383; THR-392; SER-393; SER-396;
RP   THR-397; SER-398; PRO-401; SER-406 AND SER-411, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-401 (ISOFORM 2), AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-383, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [17]
RP   VARIANT FASPS ALA-44.
RX   PubMed=15800623; DOI=10.1038/nature03453;
RA   Xu Y., Padiath Q.S., Shapiro R.E., Jones C.R., Wu S.C., Saigoh N.,
RA   Saigoh K., Ptacek L.J., Fu Y.H.;
RT   "Functional consequences of a CKIdelta mutation causing familial
RT   advanced sleep phase syndrome.";
RL   Nature 434:640-644(2005).
RN   [18]
RP   VARIANT [LARGE SCALE ANALYSIS] CYS-97.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
RN   [19]
RP   VARIANTS [LARGE SCALE ANALYSIS] CYS-97 AND ALA-401.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Casein kinases are operationally defined by their
CC       preferential utilization of acidic proteins such as caseins as
CC       substrates. It can phosphorylate a large number of proteins.
CC       Participates in Wnt signaling. Central component of the circadian
CC       clock. May act as a negative regulator of circadian rhythmicity by
CC       phosphorylating PER1 and PER2. Retains PER1 in the cytoplasm.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Exhibits substrate-dependent heparin
CC       activation.
CC   -!- SUBUNIT: Monomer. Component of the circadian core oscillator,
CC       which includes the CRY proteins, CLOCK, or NPAS2, BMAL1 or BMAL2,
CC       CSNK1D and/or CSNK1E, TIMELESS and the PER proteins. Interacts
CC       directly with PER1 and PER2 which may lead to their degradation.
CC       Interacts with DBNDD2.
CC   -!- INTERACTION:
CC       P23508:MCC; NbExp=1; IntAct=EBI-751621, EBI-307531;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus (By similarity).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P48730-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P48730-2; Sequence=VSP_010253;
CC         Note=Phosphorylated on Ser-401;
CC   -!- TISSUE SPECIFICITY: Expressed in all tissues examined, including
CC       brain, heart, lung, liver, pancreas, kidney, placenta and skeletal
CC       muscle. In blood, highly expressed in hemopoietic cells and mature
CC       granulocytes. Also found in monocytes and lymphocytes.
CC   -!- PTM: Autophosphorylated on serine and threonine residues (By
CC       similarity).
CC   -!- DISEASE: Defects in CSNK1D are a cause of familial advanced sleep-
CC       phase syndrome (FASPS) [MIM:604348]. FASPS is characterized by
CC       very early sleep onset and offset. Individuals are 'morning larks'
CC       with a 4 hours advance of the sleep, temperature and melatonin
CC       rhythms.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CK1 Ser/Thr
CC       protein kinase family. Casein kinase I subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U29171; AAC50807.1; -; mRNA.
DR   EMBL; U31285; AAC50808.1; -; mRNA.
DR   EMBL; AB091044; BAC10903.1; -; mRNA.
DR   EMBL; AK291758; BAF84447.1; -; mRNA.
DR   EMBL; EF015900; ABM64211.1; -; Genomic_DNA.
DR   EMBL; BC003558; AAH03558.1; -; mRNA.
DR   EMBL; BC015775; AAH15775.1; -; mRNA.
DR   IPI; IPI00011102; -.
DR   IPI; IPI00234463; -.
DR   PIR; G01876; G01876.
DR   RefSeq; NP_001884.2; -.
DR   RefSeq; NP_620693.1; -.
DR   UniGene; Hs.631725; -.
DR   ProteinModelPortal; P48730; -.
DR   SMR; P48730; 1-296.
DR   IntAct; P48730; 13.
DR   MINT; MINT-1454355; -.
DR   STRING; P48730; -.
DR   PhosphoSite; P48730; -.
DR   PRIDE; P48730; -.
DR   Ensembl; ENST00000314028; ENSP00000324464; ENSG00000141551.
DR   GeneID; 1453; -.
DR   KEGG; hsa:1453; -.
DR   UCSC; uc002kef.1; human.
DR   UCSC; uc002kei.1; human.
DR   CTD; 1453; -.
DR   GeneCards; GC17M080203; -.
DR   HGNC; HGNC:2452; CSNK1D.
DR   HPA; CAB015410; -.
DR   MIM; 600864; gene.
DR   MIM; 604348; phenotype.
DR   Orphanet; 164736; Familial advanced sleep-phase syndrome.
DR   PharmGKB; PA26952; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG000176; -.
DR   InParanoid; P48730; -.
DR   OMA; RMSTSQR; -.
DR   OrthoDB; EOG9Z0DRP; -.
DR   PhylomeDB; P48730; -.
DR   BRENDA; 2.7.11.1; 247.
DR   Pathway_Interaction_DB; foxopathway; FoxO family signaling.
DR   Pathway_Interaction_DB; hedgehog_glipathway; Hedgehog signaling events mediated by Gli proteins.
DR   Reactome; REACT_152; Cell Cycle, Mitotic.
DR   NextBio; 5961; -.
DR   ArrayExpress; P48730; -.
DR   Bgee; P48730; -.
DR   CleanEx; HS_CSNK1D; -.
DR   Genevestigator; P48730; -.
DR   GermOnline; ENSG00000141551; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; EXP:Reactome.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005515; F:protein binding; IPI:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0032922; P:circadian regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0006281; P:DNA repair; TAS:ProtInc.
DR   GO; GO:0090263; P:positive regulation of canonical Wnt recept...; IMP:BHF-UCL.
DR   GO; GO:0032436; P:positive regulation of proteasomal ubiquiti...; ISS:UniProtKB.
DR   GO; GO:0001934; P:positive regulation of protein amino acid p...; IMP:BHF-UCL.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IDA:UniProtKB.
DR   GO; GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0016055; P:Wnt receptor signaling pathway; IEA:UniProtKB-KW.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Complete proteome; Cytoplasm;
KW   Disease mutation; Kinase; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Serine/threonine-protein kinase; Transferase;
KW   Wnt signaling pathway.
FT   CHAIN         1    415       Casein kinase I isoform delta.
FT                                /FTId=PRO_0000192833.
FT   DOMAIN        9    277       Protein kinase.
FT   NP_BIND      15     23       ATP (By similarity).
FT   REGION      317    342       Autoinhibitory (By similarity).
FT   ACT_SITE    128    128       Proton acceptor (By similarity).
FT   BINDING      38     38       ATP (By similarity).
FT   MOD_RES     328    328       Phosphoserine.
FT   MOD_RES     329    329       Phosphothreonine.
FT   MOD_RES     331    331       Phosphoserine.
FT   MOD_RES     337    337       Phosphothreonine.
FT   MOD_RES     344    344       Phosphothreonine.
FT   MOD_RES     347    347       Phosphothreonine.
FT   MOD_RES     349    349       Phosphothreonine.
FT   MOD_RES     350    350       Phosphoserine.
FT   MOD_RES     352    352       Phosphothreonine.
FT   MOD_RES     355    355       Phosphothreonine.
FT   MOD_RES     356    356       Phosphoserine.
FT   MOD_RES     361    361       Phosphoserine.
FT   MOD_RES     382    382       Phosphoserine.
FT   MOD_RES     383    383       Phosphoserine.
FT   MOD_RES     384    384       Phosphoserine.
FT   MOD_RES     387    387       Phosphothreonine.
FT   MOD_RES     392    392       Phosphothreonine.
FT   MOD_RES     393    393       Phosphoserine.
FT   MOD_RES     396    396       Phosphoserine.
FT   MOD_RES     397    397       Phosphothreonine.
FT   MOD_RES     398    398       Phosphoserine.
FT   MOD_RES     406    406       Phosphoserine.
FT   MOD_RES     407    407       Phosphoserine.
FT   MOD_RES     411    411       Phosphoserine.
FT   VAR_SEQ     400    415       IPGRVASSGLQSVVHR -> NSIPFEHHGK (in
FT                                isoform 2).
FT                                /FTId=VSP_010253.
FT   VARIANT      44     44       T -> A (in FASPS).
FT                                /FTId=VAR_029075.
FT   VARIANT      97     97       S -> C (in breast cancer samples;
FT                                infiltrating ductal carcinoma; somatic
FT                                mutation).
FT                                /FTId=VAR_036451.
FT   VARIANT     401    401       P -> A (in dbSNP:rs56124628).
FT                                /FTId=VAR_042081.
FT   CONFLICT    330    330       A -> D (in Ref. 1; AAC50807).
SQ   SEQUENCE   415 AA;  47330 MW;  B97F1717A52466D2 CRC64;
     MELRVGNRYR LGRKIGSGSF GDIYLGTDIA AGEEVAIKLE CVKTKHPQLH IESKIYKMMQ
     GGVGIPTIRW CGAEGDYNVM VMELLGPSLE DLFNFCSRKF SLKTVLLLAD QMISRIEYIH
     SKNFIHRDVK PDNFLMGLGK KGNLVYIIDF GLAKKYRDAR THQHIPYREN KNLTGTARYA
     SINTHLGIEQ SRRDDLESLG YVLMYFNLGS LPWQGLKAAT KRQKYERISE KKMSTPIEVL
     CKGYPSEFAT YLNFCRSLRF DDKPDYSYLR QLFRNLFHRQ GFSYDYVFDW NMLKFGASRA
     ADDAERERRD REERLRHSRN PATRGLPSTA SGRLRGTQEV APPTPLTPTS HTANTSPRPV
     SGMERERKVS MRLHRGAPVN ISSSDLTGRQ DTSRMSTSQI PGRVASSGLQ SVVHR
//
